CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-27 | Creamer Victoria L EVP & Chief People Officer | Grant or award | +7,229 | 18,188 | ||
| 2023-01-27 | Barbo William D Corporate Executive VP & CCO | Grant or award | +7,857 | 11,660 | ||
| 2023-01-27 | Barbo William D Corporate Executive VP & CCO | Shares withheld for taxes | −2,897 | $244.29 | $708K | 8,763 |
| 2023-01-27 | Girshick Birgit Corporate Executive VP & COO | Grant or award | +8,435 | 44,191 | ||
| 2023-01-27 | Girshick Birgit Corporate Executive VP & COO | Shares withheld for taxes | −3,153 | $244.29 | $770K | 41,038 |
| 2023-01-27 | LaPlume Joseph W EVP, Corp Strategy & Develop | Grant or award | +8,676 | 28,908 | ||
| 2023-01-27 | LaPlume Joseph W EVP, Corp Strategy & Develop | Shares withheld for taxes | −3,261 | $244.29 | $797K | 25,647 |
| 2023-01-27 | Knell Michael Gunnar CSVP&Chief Accounting Officer | Grant or award | +2,096 | 8,534 | ||
| 2023-01-27 | Knell Michael Gunnar CSVP&Chief Accounting Officer | Shares withheld for taxes | −645 | $244.29 | $158K | 7,889 |
| 2023-01-03 | Thompson Craig B. Director | Grant or award | +244 | 244 | ||
| 2023-01-03 | Thompson Craig B. Director | Grant or award · Stock Options (Right to Buy) | +592 | $218.40 | $129K | 592 |
| 2022-12-02 | WALLMAN RICHARD F Director | Purchase | +1,500 | $218.90 | $328K | 20,114 |
| 2022-12-02 | Barbo William D Corporate Executive VP & CCO | Option exercise | +3,205 | $109.34 | $350K | 7,008 |
| 2022-12-02 | Barbo William D Corporate Executive VP & CCO | Sale | −406 | $218.28 | $89K | 6,602 |
| 2022-12-02 | Barbo William D Corporate Executive VP & CCO | Sale | −873 | $219.41 | $192K | 5,729 |
| 2022-12-02 | Barbo William D Corporate Executive VP & CCO | Sale | −1,226 | $220.14 | $270K | 4,503 |
| 2022-12-02 | Barbo William D Corporate Executive VP & CCO | Sale | −700 | $221.08 | $155K | 3,803 |
| 2022-12-02 | Barbo William D Corporate Executive VP & CCO | Option exercise · Stock Options | −3,205 | 0 | ||
| 2022-12-01 | LaPlume Joseph W EVP, Corp Strategy & Develop | Option exercise | +6,409 | $109.34 | $701K | 26,641 |
| 2022-12-01 | LaPlume Joseph W EVP, Corp Strategy & Develop | Sale | −1,138 | $223.06 | $254K | 25,503 |
Page 26 of 41 · 819 trades